共 27 条
[1]
Pentheroudakis G.(2008)Heterogeneity in cancer guidelines: should we eradicate or tolerate? Ann Oncol 19 2067-2078
[2]
Stahel R.(2009)Lung Cancer OncoGuia Clin Trans Oncol 11 805-824
[3]
Hansen H.(1999)Potential benefits, limitations and harms of clinical practice BMJ 318 527-530
[4]
Pavlidis N.(2008)CoCanCPG. Coordination of cancer clinical practice in Europe Tumori 94 154-159
[5]
Manchon P.(2008)Incorporating patient preferences in evidence-based medicine JAMA 300 2483-2484
[6]
Borràs J.M.(2006)Breast cancer guidelines: physicians, intentions, behaviours Int J Cancer 120 1136-1140
[7]
Ferro T.(2005)Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network J Clin Oncol 23 4414-4423
[8]
Espinàs J.A.(2003)From best evidence to best practice: effective implementation of change in patients care Lancet 362 1225-1230
[9]
Wolf S.H.(2005)The break even point: when medical advances are less important than improving the fidelity with which they are delivered Ann Family Med 3 545-552
[10]
Grol R.(undefined)undefined undefined undefined undefined-undefined